Clinical trial
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
NCT07770100 is registered in ClinicalTrials.gov with Mark Bernard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
- Lead sponsor
- Mark Bernard
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 9, 2026
- Completion date
- February 28, 2040
- Enrollment
- 35 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer, esophageal cancer, gastric cancer (gc), head and neck cancer, non-small cell lung cancer